Impact of Tocilizumab on the Mortality of Patients With Coronavirus Disease 2019
- PMID: 33201178
- PMCID: PMC7717218
- DOI: 10.1093/cid/ciaa1738
Impact of Tocilizumab on the Mortality of Patients With Coronavirus Disease 2019
Comment in
-
Reply to Huang et al.Clin Infect Dis. 2021 Jun 15;72(12):e1157-e1158. doi: 10.1093/cid/ciaa1739. Clin Infect Dis. 2021. PMID: 33201173 No abstract available.
-
It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).Clin Infect Dis. 2022 Feb 11;74(3):560-562. doi: 10.1093/cid/ciab480. Clin Infect Dis. 2022. PMID: 34036334 Free PMC article. No abstract available.
Comment on
-
Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies.Clin Infect Dis. 2021 Jun 1;72(11):e742-e749. doi: 10.1093/cid/ciaa1445. Clin Infect Dis. 2021. PMID: 32964913 Free PMC article.
